title: Treatment of brain metastases in non-small cell lung cancer (NSCLC) patients with epidermal growth factor receptor (EGFR) mutations: the role of EGFR tyrosine kinase inhibitors.
authors.affiliation: Breakthrough Cancer Research Unit, Pangaea Biotech S.L., Barcelona, Spain. nkarachaliou@pangaeabiotech.com.
authors.forename: Niki
authors.initials: N
authors.lastname: Karachaliou
authors.affiliation: Catalan Institute of Oncology, Hospital Germans Trias i Pujol, Badalona, Spain.
authors.forename: Rafael
authors.initials: R
authors.lastname: Rosell